09
Feb
2026
12:00
EST
17:00
GMT
Webinar
Advancing Tricuspid Valve Replacement: Real-World Outcomes and Best Practices
00
Days
00
Hours
00
Mins
00
Secs
Faculty:
Raj Makkar
Rebecca T Hahn
Fabien Praz
Rahul P Sharma
Overview
'Advancing Mitral & Tricuspid Valve Interventions: Translating Evidence and Real-World Data into Clinical Practice' is a new educational webinar series designed to deliver evidence-based education on transcatheter tricuspid and mitral valve therapies (TMTT). The programme highlights emerging clinical data, evolving guideline recommendations, and practical insights from leading international experts to support optimal patient-centred management.
The first webinar in this series, Advancing Tricuspid Valve Replacement: Real-World Outcomes and Best Practices, will focus on Transcatheter Tricuspid Valve Replacement (TTVR). This session will review the latest registry data, pivotal clinical trial results, and real-world evidence, translating new findings into clinical practice through an interactive, case-based discussion.
An expert faculty panel - Dr Raj Makkar (Cedars-Sinai Medical Center, Los Angeles, US), Dr Rebecca Hahn (Columbia University Medical Center, New York, US), Dr Fabien Praz (Bern University Hospital, Bern, CH) and Dr Rahul Sharma (Stanford University, Palo Alto, US) will work toward expert consensus on best-practice approaches for patient selection and management of tricuspid regurgitation (TR).
Register today to stay at the forefront of transcatheter valve innovation and clinical practice.
Advancing Tricuspid Valve Replacement: Real-World Outcomes and Best Practices will be planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of PeerPoint Medical Education Institute and Radcliffe Medical Education. PeerPoint Medical Education Institute is accredited by the ACCME to provide continuing medical education for physicians.
PeerPoint Medical Education Institute designates the live format for this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
This programme is supported by an unrestricted educational grant from Edwards Lifesciences.
Agenda
Learning Objectives
- List clinical trial data and real-world evidence for TTVR
- Recall guideline recommendations for TTVR
- Select appropriate patients for TTVR based on the heart-team and patient choice
- Use expert guidance to develop an evidence-based approach to managing TR with TTVR
Target Audience
- Interventional Cardiologists
- Echocardiographers
- Cardiac Surgeons
- Other Allied HCPs
Faculty Biographies
Raj Makkar
Dr Raj Makkar is a world-renowned leading expert in interventional cardiology and is one of the most widely cited researchers on the management of valvular heart disease.
Rebecca T Hahn
Rebecca T Hahn is Director of Interventional Echocardiography at New York-Presbyterian/ Columbia University Medical Center, US. She also serves as Professor of Clinical Medicine at Columbia College of Physicians and Surgeons.
Fabien Praz
Dr Fabien Praz is an interventional cardiologist at Bern University Hospital, Switzerland. His top areas of expertise are Mitral Valve Regurgitation, Tricuspid Regurgitation, Mitral Stenosis, and Aortic Valve Stenosis.
Rahul P Sharma
Dr Rahul P Sharma is Professor of Medicine at Stanford University and an Interventional Cardiologist at Stanford Health Care, where he serves as Director of Structural Interventions and Associate Director of the Cardiac Catheterisation Laboratory.